loader
Please Wait
Applying Filters...
Close
4

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Goserelin Acetate, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Goserelin Acetate

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Forms

    DRUG PRODUCT COMPOSITION

    GLOBAL SALES INFORMATION

    MARKET PLACE

    ANALYTICAL SOLUTION(s)

    DIGITAL CONTENT

    PharmaCompass

    PharmaCompass Sponsored Ads

    PharmaCompass Sponsored Ads

    2D Structure
    Also known as: 145781-92-6, Fertilan, Zoladex, Goserelin (acetate), Goserelin acetate [jan], 6yuu2pv0u8
    Molecular Formula
    C61H88N18O16
    Molecular Weight
    1329.5  g/mol
    InChI Key
    IKDXDQDKCZPQSZ-JHYYTBFNSA-N
    FDA UNII
    6YUU2PV0U8
    A synthetic long-acting agonist of GONADOTROPIN-RELEASING HORMONE. Goserelin is used in treatments of malignant NEOPLASMS of the prostate, uterine fibromas, and metastatic breast cancer.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    acetic acid;(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
    2.1.2 InChI
    InChI=1S/C59H84N18O14.C2H4O2/c1-31(2)22-40(49(82)68-39(12-8-20-64-57(60)61)56(89)77-21-9-13-46(77)55(88)75-76-58(62)90)69-54(87)45(29-91-59(3,4)5)74-50(83)41(23-32-14-16-35(79)17-15-32)70-53(86)44(28-78)73-51(84)42(24-33-26-65-37-11-7-6-10-36(33)37)71-52(85)43(25-34-27-63-30-66-34)72-48(81)38-18-19-47(80)67-38;1-2(3)4/h6-7,10-11,14-17,26-27,30-31,38-46,65,78-79H,8-9,12-13,18-25,28-29H2,1-5H3,(H,63,66)(H,67,80)(H,68,82)(H,69,87)(H,70,86)(H,71,85)(H,72,81)(H,73,84)(H,74,83)(H,75,88)(H4,60,61,64)(H3,62,76,90);1H3,(H,3,4)/t38-,39-,40-,41-,42-,43-,44-,45+,46-;/m0./s1
    2.1.3 InChI Key
    IKDXDQDKCZPQSZ-JHYYTBFNSA-N
    2.1.4 Canonical SMILES
    CC(C)CC(C(=O)NC(CCCN=C(N)N)C(=O)N1CCCC1C(=O)NNC(=O)N)NC(=O)C(COC(C)(C)C)NC(=O)C(CC2=CC=C(C=C2)O)NC(=O)C(CO)NC(=O)C(CC3=CNC4=CC=CC=C43)NC(=O)C(CC5=CN=CN5)NC(=O)C6CCC(=O)N6.CC(=O)O
    2.1.5 Isomeric SMILES
    CC(C)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)NNC(=O)N)NC(=O)[C@@H](COC(C)(C)C)NC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC3=CNC4=CC=CC=C43)NC(=O)[C@H](CC5=CN=CN5)NC(=O)[C@@H]6CCC(=O)N6.CC(=O)O
    2.2 Other Identifiers
    2.2.1 UNII
    6YUU2PV0U8
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Acetate, Goserelin

    2. Goserelin

    3. Ici 118630

    4. Ici-118630

    5. Ici118630

    6. Zoladex

    2.3.2 Depositor-Supplied Synonyms

    1. 145781-92-6

    2. Fertilan

    3. Zoladex

    4. Goserelin (acetate)

    5. Goserelin Acetate [jan]

    6. 6yuu2pv0u8

    7. Dsstox_cid_26736

    8. Dsstox_rid_81865

    9. Dsstox_gsid_46736

    10. 1-9-luteinizing Hormone-releasing Factor (swine), 6-(o-(1,1-dimethylethyl)-d-serine)-, 2-(aminocarbonyl)hydrazide, Acetate (salt)

    11. Cas-145781-92-6

    12. Ici-118630 Acetate

    13. Unii-6yuu2pv0u8

    14. Novgos

    15. Zoladex La

    16. Zoladex (tn)

    17. Ncgc00167588-02

    18. Ncgc00183275-01

    19. Schembl6094

    20. Goserelin Acetate (jan/usp)

    21. Chembl1200501

    22. Dtxsid9046736

    23. Goserelin Acetate [vandf]

    24. Goserelin Acetate [mart.]

    25. Glxc-26187

    26. Goserelin Acetate [usp-rs]

    27. Goserelin Acetate [who-dd]

    28. Tox21_112579

    29. Tox21_112937

    30. Bdbm50247974

    31. Hy-13673a

    32. Ici118630

    33. Mfcd01747329

    34. Cs-4509

    35. Goserelin Acetate [orange Book]

    36. (d-ser(tbu)6,azagly10)-lhrh Acetate

    37. Goserelin Acetate [usp Monograph]

    38. D00573

    39. 781g926

    40. Goserelin Acetate, >=99% (hplc), White Powder

    41. Q27265738

    42. Goserelin, European Pharmacopoeia (ep) Reference Standard

    43. H-pyr-his-trp-ser-tyr-d-ser(tbu)-leu-arg-pro-nhnhconh2 Acoh

    44. Goserelin Acetate, United States Pharmacopeia (usp) Reference Standard

    45. Goserelin For Nmr Identification, European Pharmacopoeia (ep) Reference Standard

    46. 6-[o-(1,1-dimethylethyl)-d-serine]-1-9-luteinizing Hormone-releasing Factor (swine) 2-(aminocarbonyl)hydrazide Acetate (salt)

    2.4 Create Date
    2007-05-07
    3 Chemical and Physical Properties
    Molecular Weight 1329.5 g/mol
    Molecular Formula C61H88N18O16
    Hydrogen Bond Donor Count18
    Hydrogen Bond Acceptor Count18
    Rotatable Bond Count32
    Exact Mass1328.66256879 g/mol
    Monoisotopic Mass1328.66256879 g/mol
    Topological Polar Surface Area533 Ų
    Heavy Atom Count95
    Formal Charge0
    Complexity2590
    Isotope Atom Count0
    Defined Atom Stereocenter Count9
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count2
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antineoplastic Agents, Hormonal

    Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079) (See all compounds classified as Antineoplastic Agents, Hormonal.)

    4.2 FDA Pharmacological Classification
    4.2.1 Pharmacological Classes
    Gonadotropin Releasing Hormone Receptor Agonists [MoA]; Gonadotropin Releasing Hormone Receptor Agonist [EPC]
    Post Enquiry
    POST ENQUIRY